Singleton Mark 4

4 · GreenLight Biosciences Holdings, PBC · Filed Feb 4, 2022

Form 4

Period: 2022-02-02

VP of Technology

Transactions

Award
Stock Option (Right to Buy)
2022-02-02+192,936→ 192,936 total
Exercise: $1.23Exp: 2031-02-09→ Common Stock (192,936 underlying)
Award
Stock Option (Right to Buy)
2022-02-02+13,399→ 13,399 total
Exercise: $1.23Exp: 2031-02-09→ Common Stock (13,399 underlying)
Award
Stock Option (Right to Buy)
2022-02-02+126,424→ 126,424 total
Exercise: $2.61Exp: 2031-06-30→ Common Stock (126,424 underlying)

Footnotes (4)

[F1]25% of the shares underlying the option vested or shall vest on February 9, 2022 and the remainder of the shares vested or shall vest in 36 equal monthly installments thereafter, starting March 9, 2022.
[F2]This option was issued pursuant to the terms of a business combination agreement involving the Issuer and GreenLight Biosciences, Inc. in exchange for a comparable option previously issued by such company.
[F3]25% of the shares underlying the option vested or shall vest on February 9, 2022 and the remainder of the shares vested or shall vest in 36 equal monthly installments thereafter, starting March 9, 2022.
[F4]25% of the shares underlying the option vested or shall vest on June 30, 2022 and the remainder of the shares vested or shall vest in 36 equal monthly installments thereafter, starting July 30, 2022.

Documents

1 file